Abstract

IL-10 has been previously described by Mossman and coworkers as a product of murine Th2 clones that inhibits the production of cytokines by Thl clones (1). Accumulated evidence now indicate that this cytokine is secreted by other cell types including monocytes and B cells and that it displays pleiotropic activities (2). Apart its stimulating and differenciating effects on B cells, IL-10 was shown to inhibit antigen presentation to T cells by acting on the antigen presenting monocytes. The recent finding that keratinocytes might be a potent source of IL-10 (3) prompted us to analyse its effect on human Langerhans cells (LC), the antigen-presenting cells from epidermis.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.